SelectScience
Join Free
Accelerating Science
ResourceLab Informatics

Orion Platform imaging for tumor-immune interactions

RareCyte, Inc
4 Jun 2024

Deeper understanding of the intricacies between tumor microenvironments and immune cell infiltrates is critical for creation of next generation therapies. In this scientific poster, RareCyte presents a single-step 15-plex fluorescence immunohistochemistry (IHC) protocol using the Orion platform to analyze tumor microenvironments and immune cell phenotypes across multiple tumor types. The poster highlights a study aimed to enhance biomarker analysis by utilizing formalin-fixed paraffin-embedded (FFPE) tumor microarrays. The results demonstrate that the Orion platform can efficiently detect 15 distinct biomarkers on a single slide, surpassing traditional methods limited to 6 markers. The method offers significant workflow advantages, reducing tissue and signal loss, and potentially leading to better diagnostic and therapeutic outcomes by providing deeper insights into immune surveillance and mechanisms of resistance in various cancers.

Related products

Request Quote for All Products

Orion Biomarkers

RareCyte, Inc

Orion Biomarkers  are tailored to enable spatial biomarker analysis with maximum flexibility. Choose from a range of labeled antibodies to generate Orion spatial biology data for multiplexed tissue imaging or create new reagents with easy-to-use conjugation kits.

(0)

Orion Multiplex Imaging Instrument

RareCyte, Inc

The Orion Platform delivers spatial biology and cellular phenotyping at a speed and resolution needed for translation from research to the clinic. It utilizes single round immunofluorescence staining and imaging of standard FFPE or fresh frozen tissue to deliver subcellular quantitation of biomarker targets across a whole slide in only a few hours. Combining speed and resolution with the additional benefits of industry-standard H&E and IHC modes, comprehensive phenotypic profiling of patient cohorts can be generated for characterization of tissue architecture, tumor heterogeneity, and the immune response. Use your own antibodies, run panels from an extensive biomarker list, or engage RareCyte services for custom panels and programs.  

(0)

Links

RareCyte, IncCompany website

Tags

In Vivo Imaging Systems<i>In vivo</i> imaging systems, including pre-clinical imaging systems and medical imaging systems are used to non-invasively visualize and capture images of live animals and plants. Monitor the natural processes or diseases of your subjects using small-animal pre-clinical imaging systems, including single photon positron emission tomography (SPECT), positron emission tomography (PET), computed tomography (micro-CT), magnetic resonance imaging (MRI), X-ray radiography, ultrasound, fluorescence and bioluminescence imagers. Multimodal systems and software solutions are also available for correlative analysis of organ, tissue, cell, or molecular-level processes. Find the best in vivo imaging products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Chem / BioinformaticsCheminformatics and bioinformatics are computational techniques used in chemistry and biology, respectively, for data acquisition, processing and storage. Cheminformatics focuses on compound information, whereas bioinformatics is mainly applied to analysis and modeling of genomics, genetic and sequencing information. Hardware and software is available for data acquisition, analysis, management and storage.ImmunohistochemistryImmunohistochemistry (IHC) is a technique used to detect specific proteins in tissue samples by using antibodies that bind to target antigens. IHC is widely applied in pathology, immunology, hematology and cancer diagnostics. Explore IHC tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.TumorsTumor research focuses on understanding abnormal cell growth that leads to cancer. Identifying biomarkers, studying tumor microenvironments, and developing targeted therapies are critical for advancing cancer treatment. Early detection and personalized treatment options are key to improving outcomes for patients. Browse our peer-reviewed product directory to explore tools for tumor research, diagnostics, and cancer therapies; compare products, read customer reviews, and get pricing directly from manufacturers.

Related resources

Orion Platform imaging for tumor-immune interactions